In vitro effects of rebaudioside A, stevioside and steviol on porcine cytochrome p450 expression and activity

被引:11
|
作者
Thogersen, Rebekka [1 ]
Petrat-Melin, Bjorn [1 ]
Zamaratskaia, Galia [2 ,3 ]
Grevsen, Kai [1 ]
Young, Jette Feveile [1 ]
Rasmussen, Martin Kroyer [1 ]
机构
[1] Aarhus Univ, Dept Food Sci, Blichers Alle 20, DK-8830 Tjele, Denmark
[2] Swedish Univ Agr Sci, Dept Mol Sci, POB 7015, SE-75007 Uppsala, Sweden
[3] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Zatisi 728-2, Vodnany 38925, Czech Republic
关键词
IPEC-J2; Primary hepatocytes; Food-drug interaction; Natural sweeteners; Stevia rebaudiana; CELL-LINE; HEPATIC MICROSOMES; NATURAL SWEETENER; NUCLEAR RECEPTORS; DRUG-METABOLISM; MESSENGER-RNA; CACO-2; INDUCTION; ENZYMES; PIGS;
D O I
10.1016/j.foodchem.2018.03.055
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The physiological effects of the Stevia-derived compounds, rebaudioside A, stevioside and steviol have been the focus of several studies due to their use as sweeteners in food. Despite that, little is known about their potential food-drug interactions. In the present study, IPEC-J2 cells and primary hepatocytes were used to investigate the effect of rebaudioside A, stevioside and steviol on cytochrome p450 (CYP) mRNA expression. Moreover, hepatic microsomes were used to investigate direct interactions between the compounds and specific CYP activity. In IPEC-J2 no changes in mRNA expression of CYP1A1 or CYP3A29 were observed with the Stevia-derived compounds. In primary hepatocytes all three tested compounds induced a significant increase in CYP3A29 expression. The tested compounds had no direct effect on specific CYP activity. In conclusion, rebaudioside A, stevioside and steviol induce only minor or no changes to the CYP expression and activity, and are not likely to cause food-drug interactions.
引用
收藏
页码:245 / 253
页数:9
相关论文
共 50 条
  • [1] In vitro effects of peimine on the activity of cytochrome P450 enzymes
    Li, Meng
    Liu, Xiaoyan
    Wang, Yuzhen
    Ju, Xiuli
    XENOBIOTICA, 2020, 50 (10) : 1202 - 1207
  • [2] Expression and Induction of Cytochrome P450 Activity in Cryopreserved Porcine Hepatocytes.
    Cursio, Raffaele
    Baldini, Edoardo
    Margara, Andrea
    Honiger, Jiri
    Saint-Paul, Marie-Christine
    Bayer, Pascal
    Raymondi, Vincent
    Rahmani, Roger
    Mouiel, Jean
    Gugenheim, Jean
    LIVER TRANSPLANTATION, 2012, 18 : S147 - S148
  • [3] In vitro effects of natural prenyloxycinnamic acids on human cytochrome P450 isozyme activity and expression
    Genovese, S.
    Epifano, F.
    Curini, M.
    Menger, D.
    Zembruski, N. C. L.
    Weiss, J.
    PHYTOMEDICINE, 2011, 18 (07) : 586 - 591
  • [4] Porcine cytochrome P450 and metabolism
    Skaanild, Mette Tingleff
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (11) : 1421 - 1427
  • [5] Comparison of human and porcine cytochrome P450 expression.
    Liu, J
    Yano, N
    Rifai, A
    Naik, S
    Santangini, H
    Trenkler, D
    Jauregui, HO
    HEPATOLOGY, 1998, 28 (04) : 493A - 493A
  • [6] Comparable constitutive expression and activity of cytochrome P450 between the lobes of the porcine liver
    Rasmussen, Martin Kroyer
    Zamaratskaia, Galia
    Ekstrand, Bo
    TOXICOLOGY IN VITRO, 2014, 28 (07) : 1190 - 1195
  • [7] In Vitro effects of cytokines on cytochrome P450 expression in human hepatocyte culture
    Dickmann, Leslie J.
    Patel, Sonal K.
    Wienkers, Larry C.
    Slatter, J. Greg
    DRUG METABOLISM REVIEWS, 2011, 43 : 117 - 117
  • [8] In vitro effects of tacrolimus on human cytochrome P450
    Lecointre, K
    Furlan, V
    Taburet, AM
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2002, 16 (06) : 455 - 460
  • [9] Regulation of cytochrome P450 gene expression and activity
    Maurel, P.
    Pascussi, J. M.
    Gerbal-Chaloin, S.
    Daujat, M.
    Vilarem, M. J.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 24 - 24
  • [10] Effect of hypoxia on cytochrome P450 activity and expression
    Fradette, C
    du Souich, P
    CURRENT DRUG METABOLISM, 2004, 5 (03) : 257 - 271